mda146n.gif (6778 bytes)

liver.jpg (2096 bytes)

arrow1.jpg (1077 bytes) Liver Cancer Q & A
stargy.jpg (1067 bytes) Liver Anatomy and Regeneration
stargy.jpg (1067 bytes) Hepatocellular Carcinoma
stargy.jpg (1067 bytes) Hepatic Colorectal Metastasis
stargy.jpg (1067 bytes)

 

Neuroendocrine Tumors in the Liver (Carcinoid and Others)
stargy.jpg (1067 bytes) Treatment Options
stargy.jpg (1067 bytes) Nonsurgical Treatment of Hepatocellular Carcinoma
stargy.jpg (1067 bytes) Ablation of Liver Tumors
stargy.jpg (1067 bytes) Current Protocols
stargy.jpg (1067 bytes) Current Research
stargy.jpg (1067 bytes) Who are the liver tumor study group specialists?
stargy.jpg (1067 bytes) Recent Publications
stargy.jpg (1067 bytes) Website Links

bsearch.gif (1824 bytes)
Search our Site!


Treatment Options

gnav.gif (4974 bytes)

Treatment Options

The treatment of primary and malignant liver tumors depends on the intrahepatic and extrahepatic extent of the disease and the function of the underlying liver. The various options in the treatment of focal liver masses are as follows:

Surgical

  • Resection

  • Unroofing and marsupialization

  • Fenestration and resection

  • Enucleation

  • Cryoablation

  • Radiofrequency ablation

  • Transplantation


Nonsurgical

  • Hepatic artery infusion (port or pump)

  • Embolization and chemoembolization

  • Alcohol ablation

For malignant liver neoplasms, in the absence of extrahepatic disease, resection with negative pathological margins is the mainstay of treatment. Major typical or atypical anatomical resections can now be carried out with low morbidity and minimal mortality. Extended resections – up to 75% of liver – can be safely performed in patients without underlying liver disease provided liver function is not compromised by hypotension, infection or ischemic injury. Major typical anatomical resections with the various nomenclatures used in the surgical literature are outlined in the following figure.

New techniques such as enucleation or ablation are available where parenchymal–sparing procedures are needed. In addition, other interventions such as hepatic artery embolization of tumors and, in some cases, portal vein embolization of a lobe or more have allowed preoperative downstaging of some tumors and the "remodeling" of nontumoral hepatic parenchyma in anticipation of major resection. An accurate diagnosis and precise determination of the extent of disease are essential.

Back to Top

             gnav.gif (4974 bytes)

©1999    The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
1-800-392-1611 (USA) / 1-713-792-6161
   Legal Disclaimer